The major side effect of concern with Eloxatin ( oxaliplatin ) is the progressive loss of feeling or function in fingers or toes. That is a small price to pay when extending metastatic colon cancer survival from a few months to a few years.

Occasionally, studies of medical data find unexpected trends. Recently, an analysis of anesthetic use during liver surgery found a surprising relationship for tumor recurrence.

Pregnant women undergoing cancer therapy worry that the treatment will hurt their baby's health. But rest assured, chemotherapy does not put a growing baby at risk of health problems, reports a new study.

Prostate cancer doesn't occur in isolation, and recent research may give some peace of mind to prostate cancer patients already on medication for arthritis or high cholesterol.

Finding genetic alterations is one tedious undertaking. While it's becoming a less expensive proposition, genomic sequencing is still rigorous. New technology may change that and provide pictures in the meantime.

Previously, researchers thought that the causes of bladder cancers were similar, but it appears that's not the case.

The Food & Drug Administration (FDA) plays a difficult role in drug approval, and no matter what the agency decides, someone is upset. The recent decision on expanding Xgeva's treatment in prostate cancer illustrates that once again.

T cells are the beat cops of the immune system, and they constantly patrol around the body looking for critters. T cells recognizing and destroying weird cells is also one of the most effective defenses of the body against cancer.

Treating childhood cancers usually requires medications, some of which can be toxic to the heart. So will these drugs cause heart problems later on in life?  Recent research asked just that question.

A common story in cancer treatment is of specialized drugs that work great initially, but over time the cancer becomes resistant to the drug. Finding out why this happens has become paramount for scientists.